...
首页> 外文期刊>Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis >Effect of BIX-01294 on proliferation, apoptosis and histone methylation of acute T lymphoblastic leukemia cells
【24h】

Effect of BIX-01294 on proliferation, apoptosis and histone methylation of acute T lymphoblastic leukemia cells

机译:BIX-01294对急性T淋巴细胞白血病细胞增殖,细胞凋亡和组甲基化的影响

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Highlights ? BIX-01294 inhibits Bcl-2, upregulates Bax and caspase-3 and induces cell apoptosis. ? BIX-01294 upregulates P21 and induces cell cycle arrest in the phase G0/G1. ? BIX-01294 downregulates histone H3K9 mono- and di-methylation levels. ? BIX-01294 inhibits the proliferation of acute T lymphoblastic leukemia cells. Abstract Objective To determine effect of G9a inhibitor BIX-01294 on proliferation, apoptosis and histone methylation of acute T lymphoblastic leukemia cells (MOLT-4 and Jurkat) and to explore the underlying mechanism. Methods Cell proliferation was detected by MTT assay and apoptosis and cell cycle were measured by flow cytometry. Western blot was performed to determine expression of caspase-3, Bcl-2, Bax, P21, P15 and DNMT1 as well as levels of histone H3 acetylation, histone H3K9 mono- di- and tri-methylation. Results BIX-01294 inhibits expression of Bcl-2, upregulates expression of Bax and caspase-3 and induces cell apoptosis. BIX-01294 upregulates cell cycle inhibitor P21 expression and induces cell cycle arrest in the phase G0/G1. Furthermore, BIX-01294 suppresses expression of DNA demethylase DNMT1 and promotes expression of tumor suppressor protein P15, thereby inhibiting proliferation of MOLT-4 and Jurkat cells. BIX-01294 downregulates histone H3K9 mono- and di-methylation levels and has no effect on H3K9 trimethylation and histone H3 acetylation. Conclusion Taken together, our results indicate that by regulating H3K9 methylation and cell cycle, BIX-01294 inhibits the proliferation and induces apoptosis of acute T lymphoblastic leukemia cells.
机译:强调 ? BIX-01294抑制Bcl-2,上调Bax和Caspase-3并诱导细胞凋亡。还Bix-01294上调P21并在G0 / G1中诱导细胞周期停滞。还BIX-01294下调组蛋白H3K9单 - 和二甲基化水平。还BIX-01294抑制急性T淋巴细胞白血病细胞的增殖。摘要目的确定G9A抑制剂BIX-01294对急性T淋巴细胞白血病细胞(Molt-4和Jurkat)增殖,凋亡和组甲基化的影响,探讨潜在机制。方法通过MTT测定检测细胞增殖,通过流式细胞术测量细胞凋亡和细胞周期。进行蛋白质印迹以确定Caspase-3,Bcl-2,Bax,P21,P15和DNMT1的表达以及组蛋白H3乙酰化的水平,组蛋白H3K9单二 - 和三甲基化。结果BIX-01294抑制Bcl-2的表达,上调Bax和Caspase-3的表达,并诱导细胞凋亡。 BIX-01294上调细胞周期抑制剂P21表达,并在相阶段G0 / G1中诱导细胞周期停滞。此外,BIX-01294抑制DNA脱甲基酶DNMT1的表达并促进肿瘤抑制蛋白P15的表达,从而抑制MOLT-4和JURKAT细胞的增殖。 BIX-01294下调组蛋白H3K9单 - 和二甲基化水平,对H3K9三甲基化和组蛋白H3乙酰化没有影响。结论结束,我们的结果表明,通过调节H3K9甲基化和细胞周期,BIX-01294抑制急性T淋巴细胞白血病细胞的增殖和诱导细胞凋亡。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号